HOME >> MEDICINE >> NEWS
Wiley announces partnership with NASPGHAN and AASLD

Hoboken, N.J., September 6, 2006 -- Global publisher John Wiley & Sons, Inc., today announced a new agreement with the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) and the American Association for the Study of Liver Diseases (AASLD) whereby Wiley will provide complimentary subscriptions of the journal Hepatology to all NASPGHAN fellows. Hepatology is an official journal of AASLD and is published on behalf of the Association by Wiley.

Hepatology is the premier worldwide journal publishing original, peer-reviewed articles concerning all aspects of liver structure, function, and disease.

"As chair of the AASLD Publications Committee, I am pleased that our publisher, John Wiley & Sons, Inc. is providing Hepatology without charge to trainees in Pediatric Gastroenterology/Hepatology," said William Balistreri, M.D. "Hepatology is the premier journal in the field and access to the important basic and translational research published in its pages will stimulate young investigators and we hope lead to the improved care of children with hepatobiliary disease."

"NASPGHAN welcomes this partnership with AASLD and Wiley and appreciates the generous support extended to the training and educating of our next generation of pediatric gastroenterologists," said Philip M. Sherman, M.D., President of NASPGHAN.


'"/>

Contact: David Greenberg
dgreenbe@wiley.com
201-748-6484
John Wiley & Sons, Inc.
6-Sep-2006


Page: 1

Related medicine news :

1. The Society of Hospital Medicine and Wiley to launch InfoPOEMs for hospitalists
2. Wiley acquires HEED, the worlds leading Health Economic Evaluations Database
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Wiley expands partnership with Skyscape
5. Crohns & Colitis Foundation of America selects Wiley to publish Inflammatory Bowel Diseases
6. Wiley wins two 2005 PSP awards and three honorable mentions
7. Wiley acquires InfoPOEM, Inc.
8. New book on independent living through smart technologies available from Wiley
9. Wiley to publish UICC TNM Atlas in July 2005
10. W.M. Keck Foundation announces 2007 class of Distinguished Young Scholars in medical research
11. AstraZeneca announces SYMBICORT is now available in the US

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or from ... how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional supplements, ... symptoms of AMD? A study published recently in Dove Medical Press journal, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. Ran ... York, has recently begun offering three new minimally invasive procedures to patients who ... and reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, and ...
(Date:6/23/2017)... ... June 23, 2017 , ... Everybody has their own ... others prefer to read it, and some people don't like it at all. FindaTopDoc ... what they found: , Erotic literature can give readers a taste of their deepest, ...
(Date:6/23/2017)... Beverly Hills, CA (PRWEB) , ... June 23, 2017 , ... ... deep plane facelift . Dr. Talei has come up with a proprietary technique ... wrinkles—it releases and lifts tissues that have dropped. For all ages, patients can expect ...
(Date:6/23/2017)... ... June 23, 2017 , ... ... Conference from Sept. 18 to 20. , The two-day conference is focused on ... the goal of improving patients’ lives and eliminating racial breast cancer-related disparities. The ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... , June 8, 2017  Less than a month ... more than 200,000 companies, including hospital networks, in over ... as one of the largest online extortion attempts ever ... healthcare market, it is imperative that providers understand where ... data from this — and many other very real ...
(Date:6/7/2017)... 2017  Novavax, Inc., (Nasdaq: NVAX ) today ... trials of its RSV F protein recombinant nanoparticle vaccine candidate ... been published in the journal Vaccine ... prior scientific conferences). The Company previously announced top line ... developing the RSV F Vaccine with the goal of protecting ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly and ... that results from the Phase 3 MONARCH 2 ... & 6 inhibitor, in combination with fulvestrant, significantly ... fulvestrant alone in women with hormone-receptor-positive (HR+), human ... cancer who have relapsed or progressed after endocrine ...
Breaking Medicine Technology:
Cached News: